Caxton Associates (New York)’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$719K Sell
4,414
-1,087
-20% -$194K 0.02% 272
2024
Q3
$1.07M Buy
+5,501
New +$1.01M 0.04% 231
2024
Q2
Sell
-10,106
Closed -$1.71M 618
2024
Q1
$1.71M Buy
+10,106
New +$1.89M 0.1% 148
2023
Q3
Sell
-10,973
Closed -$1.89M 624
2023
Q2
$1.89M Buy
+10,973
New +$1.9M 0.28% 71
2023
Q1
Sell
-7,564
Closed -$1.11M 664
2022
Q4
$1.11M Sell
7,564
-1,967
-21% -$291K 0.07% 103
2022
Q3
$1.41M Buy
9,531
+5,027
+112% +$840K 0.19% 57
2022
Q2
$774K Buy
4,504
+2,946
+189% +$510K 0.08% 182
2022
Q1
$294K Buy
1,558
+437
+39% +$86.4K 0.02% 364
2021
Q4
$274K Buy
+1,121
New +$246K 0.03% 438
2020
Q4
Sell
-1,419
Closed -$235K 346
2020
Q3
$235K Buy
+1,419
New +$218K 0.02% 235
2020
Q1
Sell
-3,191
Closed -$422K 618
2019
Q4
$422K Buy
+3,191
New +$397K 0.06% 206
2019
Q2
Sell
-4,277
Closed -$431K 545
2019
Q1
$431K Sell
4,277
-329
-7% -$29.9K 0.06% 174
2018
Q4
$394K Sell
4,606
-3,505
-43% -$316K 0.06% 140
2018
Q3
$743K Buy
+8,111
New +$720K 0.05% 179
2017
Q4
Sell
-3,900
Closed -$249K 556
2017
Q3
$249K Buy
+3,900
New +$244K 0.01% 458
2017
Q2
Sell
-9,900
Closed -$528K 588
2017
Q1
$528K Buy
+9,900
New +$535K ﹤0.01% 234
2015
Q2
Sell
-100,000
Closed -$4.63M 215
2015
Q1
$4.63M Buy
+100,000
New +$4.51M 0.19% 82

Other funds holding ZTS

Caxton Associates (New York)'s ZTS Position: Q4 2024 in Review

Caxton Associates (New York) reduced its Zoetis (ZTS) stake by 20% in Q4 2024, selling an estimated $194K and leaving 4,414 shares worth $719K. The position accounts for 0.02% of the portfolio, ranked #272.

Caxton Associates (New York) first reported a position in ZTS in Q1 2015 and has held it in 17 quarters since. The position peaked at $4.63M in Q1 2015. 1,875 funds tracked by Wall St. Rank hold ZTS as of Q4 2024.

  • Caxton Associates (New York) held 4,414 shares of Zoetis worth $719K as of Q4 2024.
  • Caxton Associates (New York) sold 1,087 Zoetis shares in Q4 2024, an estimated $194K.
  • Zoetis made up 0.02% of Caxton Associates (New York)'s portfolio in Q4 2024, its #272 holding.
  • Caxton Associates (New York) first reported a position in Zoetis in Q1 2015 and has held it in 17 quarters since.
  • Caxton Associates (New York)'s Zoetis position peaked at $4.63M in Q1 2015.
  • 1,875 funds tracked by Wall St. Rank held Zoetis as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.